The First-rate and Fastest-growing Biological CDMO Services in the World
Cytovance® Biologics, Hepalink’s wholly-owned subsidiary located in North America, is a world leading Contract Development and Manufacturing Organization (CDMO) that specializes in recombinant and naturally derived macromolecule and gene therapy products. Our CDMO platform not only boasts robust microbial  and mammalianprocess development and production capabilities but is also emerging  in the flourishing gene therapy market. With high-quality services and unique technological superiority, Cytovance has gained the trust of important customers, brought us more innovative products, helped us screen new drugs more accurately, and sped up the development of existing pipeline products.
Process development service

Cell Line Development
Escherichia coli Keystone Expression Systeem
Mammalian Cell Culture Process Development
Microbial Fermentation Development
Pre-Formulation Stability Testint
Refold and Purification Development
Purification Development
Process Transfer
Analytical Method Transfer Development Qualification
Process Characterizatios


Manufacturing service

Mammalian Cell Culture
Microbial Fermentation
Mass Refolding
Purification and Separation
Customized DS Manufacturing
Microbial and Mammalian Cell Banking
Process Validation

Development Support Sservices

Project Management
QA/QC
Validation of Analytical Method
Raw Material Management
Stability Test
Regulatory Support

© 2020 Hepalink Group All Rights Reserved.粤ICP备11096806号-1